The United States’ response to addiction and substance use disorders is a criminal justice response and not a public health response — but it shouldn’t be that way, one expert said at Engage at HLTH.
The startup began with digital tobacco cessation programs, but recently expanded to programs for alcohol use disorder and opioid use disorder. The $64 million funding round was led by Kinnevik and Atomico.
In a recent interview, Esperion president and CEO, Sheldon Koenig talks about the reality of statin intolerance and his company’s expansion into new diseases